Mechanically compliant coatings in neural implants as a strategy to reduce foreign body reaction in the peripheral nervo...
Mechanically compliant coatings in neural implants as a strategy to reduce foreign body reaction in the peripheral nervo...
Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardi...
...
Recent studies reported that cAMP-binding protein Epac1-deficient mice were protected against various forms of cardiac stress, suggesting that pharmacological inhibition of Epac1 could be beneficial for the treatment of cardiac diseases. To test this assumption, we characterized an Epac1-selective inhibitory compound and investigated its potential ...
Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardi...
...
Recent studies reported that cAMP-binding protein Epac1-deficient mice were protected against various forms of cardiac stress, suggesting that pharmacological inhibition of Epac1 could be beneficial for the treatment of cardiac diseases. To test this assumption, we characterized an Epac1-selective inhibitory compound and investigated its potential ...
Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardi...
...
Recent studies reported that cAMP-binding protein Epac1-deficient mice were protected against various forms of cardiac stress, suggesting that pharmacological inhibition of Epac1 could be beneficial for the treatment of cardiac diseases. To test this assumption, we characterized an Epac1-selective inhibitory compound and investigated its potential ...
Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardi...
...
Recent studies reported that cAMP-binding protein Epac1-deficient mice were protected against various forms of cardiac stress, suggesting that pharmacological inhibition of Epac1 could be beneficial for the treatment of cardiac diseases. To test this assumption, we characterized an Epac1-selective inhibitory compound and investigated its potential ...
Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardi...
...
Recent studies reported that cAMP-binding protein Epac1-deficient mice were protected against various forms of cardiac stress, suggesting that pharmacological inhibition of Epac1 could be beneficial for the treatment of cardiac diseases. To test this assumption, we characterized an Epac1-selective inhibitory compound and investigated its potential ...
CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes
CEMIP (for “Cell migration-inducing protein” also called KIAA1199 and Hybid for “Hyaluronan-binding protein”) expression is increased in cancers and described as a regulator of cell survival, growth and invasion. In rheumatoid arthritis, CEMIP is referred to as an angiogenic marker and participates in hyaluronic acid degradation. In this study, CEM...
CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes
CEMIP (for “Cell migration-inducing protein” also called KIAA1199 and Hybid for “Hyaluronan-binding protein”) expression is increased in cancers and described as a regulator of cell survival, growth and invasion. In rheumatoid arthritis, CEMIP is referred to as an angiogenic marker and participates in hyaluronic acid degradation. In this study, CEM...
CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes
CEMIP (for “Cell migration-inducing protein” also called KIAA1199 and Hybid for “Hyaluronan-binding protein”) expression is increased in cancers and described as a regulator of cell survival, growth and invasion. In rheumatoid arthritis, CEMIP is referred to as an angiogenic marker and participates in hyaluronic acid degradation. In this study, CEM...
